Published :
Tables : 58
Figures : 48
Category : Healthcare
No. of Pages : 216
Report Code : HC-U3404
Multiplex Assay Market is poised to value USD 4978.44 million by 2028 end at a CAGR of 7.6% during the forecast period 2022 to 2028. The growing acceptance of companion diagnostics for increasing the efficacy and safety of therapeutics and the benefits of multiplex assays over traditional single plex assays are some of the major factors responsible for the multiplex assay market growth. Multiplex assays profile different analytes like biomolecules, proteins, chemokines, cytokines by quantifying and detecting them at the same time. These assays are used for amplifying different targets in a PCR and for collecting more insights from miniscule protein quantities in less time in comparison to traditional methods like ELISA. The assays are prominently utilized for identifying pathogens, analysis of mutations, gene detection analysis, RNA detection, forensic studies, linkage analysis, etc. The rising research and development activities for treating multiple disorders shall bolster the proliferation of the market. Conventional anticancer therapies have used multiples assays in limited ways. The TDM offers valuable insights for the adjusting the dosage of immunosuppressants, antiepileptics, antibiotics and other drugs. The necessity of different samples of blood for defining the exposure of anticancer drugs systematically has been one of the key problems while testing the therapeutics for anticancer. However, the TDM services are expensive and small hospitals, especially in developing nations, are reluctant on providing these services which is one of the key limiting factors responsible for the growth of the market. Multiplex Assay Market Segmentation: By Product and Service • Consumables • Instruments • Software and Services By Type • Protein Multiplex Assays o Planar Protein Assays o Bead-Based Protein Assays o Other Protein Assays • Nucleic Acid Multiplex Assays o Planar Nucleic Acid Assays o Bead-Based Nucleic Acid Assays o Other Nucleic Acid Assays • Cell-Based Multiplex Assays By Technology • Flow Cytometry • Fluorescence Detection • Luminescence • Multiplex Real-Time PCR • Other Technologies By Application • Research & Development o Drug Discovery & Development o Biomarker Discovery & Validation • Clinical Diagnostics o Infectious Diseases o Cancer o Cardiovascular Diseases o Autoimmune Diseases o Nervous System Disorders o Metabolism & Endocrinology Disorders o Other Diseases By End User • Pharmaceutical & Biotechnology Companies • Hospitals & Research Institutes • Reference Laboratories • Other End Users By Region • North America • Europe • Asia Pacific • Latin America • Middle East & Africa The market is fragmented into product, type, application, end user and region. The product segment is categorized into consumables and equipment. The consumables segment is predicted to hold the largest multiples assays market share due to the necessity of repeated purchase of reagents along with the rise in the number of tests performed worldwide. The type segment is diversified into nuclei acid and protein cell. The technology segment is classified into luminescence and flow cytometry. The end user segment is divided into pharma & biotech, reference laboratory and hospital. Regional Analysis: The North America region is anticipated to lead the market owing to the rising per capita expenditure on healthcare, technological advancements in healthcare infrastructure, growing initiatives by the government bodies, increased disposable income. Competitive Landscape: Some of the key market players associated are Abbott Laboratories, Hoffmann-La Roche, Siemens Healthineers, Thermo Fisher Scientific, Danaher Corporation, Bio-Rad Laboratories, Biomérieux, Bühlmann Laboratories, Sekisui Medical, Randox Laboratories. FutureWise Key Takeaways: • Growth prospects • SWOT analysis • Key market trends • Key data-points affecting market growth Objectives of the Study: • To provide with an exhaustive analysis on the global multiplex assays market by product, by type, by technology, by application, by end user and by region • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) • To evaluate and forecast micro-markets and the overall market • To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific, Latin America and Middle East and Africa • To record, evaluate and analyze competitive landscape mapping- product launches, technological advancements, mergers, and expansions Flexible Delivery Model: • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement • The customization Mobility Care offered are free of charge with purchase of any license of the report • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com
The growing acceptance of companion diagnostics for increasing the efficacy and safety of therapeutics and the benefits of multiplex assays over traditional single plex assays are some of the major factors responsible for the multiplex assay market growth. Multiplex assays profile different analytes like biomolecules, proteins, chemokines, cytokines by quantifying and detecting them at the same time. These assays are used for amplifying different targets in a PCR and for collecting more insights from miniscule protein quantities in less time in comparison to traditional methods like ELISA. The assays are prominently utilized for identifying pathogens, analysis of mutations, gene detection analysis, RNA detection, forensic studies, linkage analysis, etc. The rising research and development activities for treating multiple disorders shall bolster the proliferation of the market. Conventional anticancer therapies have used multiples assays in limited ways. The TDM offers valuable insights for the adjusting the dosage of immunosuppressants, antiepileptics, antibiotics and other drugs. The necessity of different samples of blood for defining the exposure of anticancer drugs systematically has been one of the key problems while testing the therapeutics for anticancer. However, the TDM services are expensive and small hospitals, especially in developing nations, are reluctant on providing these services which is one of the key limiting factors responsible for the growth of the market.
Multiplex Assay Market Segmentation: By Product and Service • Consumables • Instruments • Software and Services By Type • Protein Multiplex Assays o Planar Protein Assays o Bead-Based Protein Assays o Other Protein Assays • Nucleic Acid Multiplex Assays o Planar Nucleic Acid Assays o Bead-Based Nucleic Acid Assays o Other Nucleic Acid Assays • Cell-Based Multiplex Assays By Technology • Flow Cytometry • Fluorescence Detection • Luminescence • Multiplex Real-Time PCR • Other Technologies By Application • Research & Development o Drug Discovery & Development o Biomarker Discovery & Validation • Clinical Diagnostics o Infectious Diseases o Cancer o Cardiovascular Diseases o Autoimmune Diseases o Nervous System Disorders o Metabolism & Endocrinology Disorders o Other Diseases By End User • Pharmaceutical & Biotechnology Companies • Hospitals & Research Institutes • Reference Laboratories • Other End Users By Region • North America • Europe • Asia Pacific • Latin America • Middle East & Africa
The market is fragmented into product, type, application, end user and region. The product segment is categorized into consumables and equipment. The consumables segment is predicted to hold the largest multiples assays market share due to the necessity of repeated purchase of reagents along with the rise in the number of tests performed worldwide. The type segment is diversified into nuclei acid and protein cell. The technology segment is classified into luminescence and flow cytometry. The end user segment is divided into pharma & biotech, reference laboratory and hospital.
Regional Analysis: The North America region is anticipated to lead the market owing to the rising per capita expenditure on healthcare, technological advancements in healthcare infrastructure, growing initiatives by the government bodies, increased disposable income.
Competitive Landscape: Some of the key market players associated are Abbott Laboratories, Hoffmann-La Roche, Siemens Healthineers, Thermo Fisher Scientific, Danaher Corporation, Bio-Rad Laboratories, Biomérieux, Bühlmann Laboratories, Sekisui Medical, Randox Laboratories.
FutureWise Key Takeaways: • Growth prospects • SWOT analysis • Key market trends • Key data-points affecting market growth
Objectives of the Study: • To provide with an exhaustive analysis on the global multiplex assays market by product, by type, by technology, by application, by end user and by region • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) • To evaluate and forecast micro-markets and the overall market • To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific, Latin America and Middle East and Africa • To record, evaluate and analyze competitive landscape mapping- product launches, technological advancements, mergers, and expansions
Flexible Delivery Model: • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement • The customization Mobility Care offered are free of charge with purchase of any license of the report • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com
1. Market Introduction 1.1. Objectives of the Study 1.2. Market Definition 1.3. Market Scope 1.3.1. Years Considered for the Study 1.3.2. Market Covered 1.4. Currency 1.5. Limitations 1.6. Stakeholders 2. Research Methodology 2.1. Research Data 2.1.1. Secondary Data 2.1.1.1. Key Data from Secondary Sources 2.1.2. Primary Data 2.1.2.1. Key Data from Primary Sources 2.2. Market Size Estimation 2.3. Market Breakdown and Data Triangulation 2.4. Assumptions for the Study 3. Executive Summary 3.1. Market Outlook 3.2. Segment Outlook 3.3. Competitive Insights 4. Multiplex Assay Market Variables, Trends & Scope 4.1. Market Lineage Outlook 4.2. Penetration and Growth Prospect Mapping 4.3. Industry Value Chain Analysis 4.4. Cost Analysis Breakdown 4.5. Technology Overview 4.6. Regulatory Framework 4.6.1. Reimbursement Framework 4.6.2. Standards and Compliances 5. Market Overview 5.1. Market Dynamics 5.1.1. Market Driver Analysis 5.1.1.1. Increasing focus of Multiplex Assay Market Companies on Brand Protection 5.1.1.2. Untapped Opportunities in Emerging Regions 5.1.2. Market Restraint Analysis 5.1.2.1. High Cost Associated with Implementation of Predictive Analysis 5.1.3. Industry Challenges 5.1.3.1. Presence of Ambiguous Regulatory Framework 6. Multiplex Assay Market Analysis Tools 6.1. Industry Analysis - Porter’s 6.1.1. Supplier Power 6.1.2. Buyer Power 6.1.3. Substitution Threat 6.1.4. Threat from New Entrants 6.1.5. Competitive Rivalry 6.2. Pestel Analysis 6.2.1. Political Landscape 6.2.2. Environmental Landscape 6.2.3. Social Landscape 6.2.4. Technology Landscape 6.2.5. Legal Landscape 6.3. Major Deals And Strategic Alliances Analysis 6.3.1. Joint Ventures 6.3.2. Mergers and Acquisitions 6.3.3. Licensing and Partnership 6.3.4. Technology Collaborations 6.3.5. Strategic Divestments 6.4. Market Entry Strategies 6.5. Case Studies 7. Multiplex Assay Market, By Product and Service Historical Analysis and Forecast 2022-2028 (USD Million) 7.1. Consumables 7.2. Instruments 7.3. Software and Services 8. Multiplex Assay Market, By Type Historical Analysis and Forecast 2022-2028 (USD Million) 8.1. Protein Multiplex Assays 8.1.1. Planar Protein Assays 8.1.2. Bead-Based Protein Assays 8.1.3. Other Protein Assays 8.2. Nucleic Acid Multiplex Assays 8.2.1. Planar Nucleic Acid Assays 8.2.2. Bead-Based Nucleic Acid Assays 8.2.3. Other Nucleic Acid Assays 8.3. Cell-Based Multiplex Assays 9. Multiplex Assay Market, By Technology Historical Analysis and Forecast 2022-2028 (USD Million) 9.1. Flow Cytometry 9.2. Fluorescence Detection 9.3. Luminescence 9.4. Multiplex Real-Time PCR 9.5. Other Technologies 10. Multiplex Assay Market, By Applications Historical Analysis and Forecast 2022-2028 (USD Million) 10.1. Research & Development 10.1.1. Drug Discovery & Development 10.1.2. Biomarker Discovery & Validation 10.2. Clinical Diagnostics 10.2.1. Infectious Diseases 10.2.2. Cancer 10.2.3. Cardiovascular Diseases 10.2.4. Autoimmune Diseases 10.2.5. Nervous System Disorders 10.2.6. Metabolism & Endocrinology Disorders 10.2.7. Other Diseases 11. Multiplex Assay Market, By End User Historical Analysis and Forecast 2022-2028 (USD Million) 11.1. Pharmaceutical & Biotechnology Companies 11.2. Hospitals & Research Institutes 11.3. Reference Laboratories 11.4. Other End Users 12. North America Multiplex Assay Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 12.1. Introduction 12.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 12.2.1. U.S.A 12.2.2. Canada 12.2.3. Mexico 12.3. Market Size (USD Million) Forecast for North America 2022-2028 13. Latin America Multiplex Assay Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 13.1. Introduction 13.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 13.2.1. Brazil 13.2.2. Venezuela 13.2.3. Argentina 13.2.4. Rest of Latin America 13.3. Market Size (USD Million) Forecast for Latin America 2022-2028 14. Europe Multiplex Assay Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 14.1. Introduction 14.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 14.2.1. Germany 14.2.2. U.K 14.2.3. France 14.2.4. Italy 14.2.5. Spain 14.2.6. Russia 14.2.7. Poland 14.2.8. Rest of Europe 14.3. Market Size (USD Million) Forecast for Europe 2022-2028 15. Asia Pacific Multiplex Assay Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 15.1. Introduction 15.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 15.2.1. Japan 15.2.2. China 15.2.3. India 15.2.4. Australia and New Zealand 15.2.5. ASEAN 15.2.6. Rest of Asia Pacific 15.3. Market Size (USD Million) Forecast for Asia Pacific 2022-2028 16. Middle East and Africa Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 16.1. Introduction 16.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 16.2.1. GCC 16.2.2. Israel 16.2.3. South Africa 16.2.4. Rest of MEA 16.3. Market Size (USD Million) Forecast for MEA 2022-2028 17. Market Share Analysis and Competitive Landscape 17.1. Global Landscape - Key Players, Revenue and Presence 17.2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3) 17.3. Global Emerging Companies 17.4. North America - Market Share Analysis and Key Regional Players 17.5. Europe - Market Share Analysis and Key Regional Players 17.6. Asia Pacific - Market Share Analysis and Key Regional Players 17.7. Global Key Player - Growth Matrix 18. Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts) 18.1. Abbott Laboratories 18.1.1. Company Overview 18.1.2. Product Portfolio 18.1.3. SWOT Analysis 18.1.4. Financial Overview 18.1.5. Strategic Overview 18.2. Hoffmann-La Roche 18.2.1. Company Overview 18.2.2. Product Portfolio 18.2.3. SWOT Analysis 18.2.4. Financial Overview 18.2.5. Strategic Overview 18.3. Siemens Healthineers 18.3.1. Company Overview 18.3.2. Product Portfolio 18.3.3. SWOT Analysis 18.3.4. Financial Overview 18.3.5. Strategic Overview 18.4. Thermo Fisher Scientific 18.4.1. Company Overview 18.4.2. Product Portfolio 18.4.3. SWOT Analysis 18.4.4. Financial Overview 18.4.5. Strategic Overview 18.5. Danaher Corporation 18.5.1. Company Overview 18.5.2. Product Portfolio 18.5.3. SWOT Analysis 18.5.4. Financial Overview 18.5.5. Strategic Overview 18.6. Bio-Rad Laboratories 18.6.1. Company Overview 18.6.2. Product Portfolio 18.6.3. SWOT Analysis 18.6.4. Financial Overview 18.6.5. Strategic Overview 18.7. Biomérieux 18.7.1. Company Overview 18.7.2. Product Portfolio 18.7.3. SWOT Analysis 18.7.4. Financial Overview 18.7.5. Strategic Overview 18.8. Bühlmann Laboratories 18.8.1. Company Overview 18.8.2. Product Portfolio 18.8.3. SWOT Analysis 18.8.4. Financial Overview 18.8.5. Strategic Overview 18.9. Sekisui Medical 18.9.1. Company Overview 18.9.2. Product Portfolio 18.9.3. SWOT Analysis 18.9.4. Financial Overview 18.9.5. Strategic Overview 18.10.Randox Laboratories 18.10.1. Company Overview 18.10.2. Product Portfolio 18.10.3. SWOT Analysis 18.10.4. Financial Overview 18.10.5. Strategic Overview 19. Pre and Post COVID-19 Impact 19.1. Positive influence on the healthcare industry 19.2. The financial disruption of the manufacturing sector 19.3. Impact of COVID-19 on emerging companies 19.4. Significant mandates in the healthcare regulations initiated by administrations 19.5. The overall economic slowdown of the developing and developed nations 20. FutureWise SME Key Takeaway Points for Client
1. Market Introduction 1.1. Objectives of the Study 1.2. Market Definition 1.3. Market Scope 1.3.1. Years Considered for the Study 1.3.2. Market Covered 1.4. Currency 1.5. Limitations 1.6. Stakeholders
2. Research Methodology 2.1. Research Data 2.1.1. Secondary Data 2.1.1.1. Key Data from Secondary Sources 2.1.2. Primary Data 2.1.2.1. Key Data from Primary Sources 2.2. Market Size Estimation 2.3. Market Breakdown and Data Triangulation 2.4. Assumptions for the Study
3. Executive Summary 3.1. Market Outlook 3.2. Segment Outlook 3.3. Competitive Insights
4. Multiplex Assay Market Variables, Trends & Scope 4.1. Market Lineage Outlook 4.2. Penetration and Growth Prospect Mapping 4.3. Industry Value Chain Analysis 4.4. Cost Analysis Breakdown 4.5. Technology Overview 4.6. Regulatory Framework 4.6.1. Reimbursement Framework 4.6.2. Standards and Compliances
5. Market Overview 5.1. Market Dynamics 5.1.1. Market Driver Analysis 5.1.1.1. Increasing focus of Multiplex Assay Market Companies on Brand Protection 5.1.1.2. Untapped Opportunities in Emerging Regions 5.1.2. Market Restraint Analysis 5.1.2.1. High Cost Associated with Implementation of Predictive Analysis 5.1.3. Industry Challenges 5.1.3.1. Presence of Ambiguous Regulatory Framework
6. Multiplex Assay Market Analysis Tools 6.1. Industry Analysis - Porter’s 6.1.1. Supplier Power 6.1.2. Buyer Power 6.1.3. Substitution Threat 6.1.4. Threat from New Entrants 6.1.5. Competitive Rivalry 6.2. Pestel Analysis 6.2.1. Political Landscape 6.2.2. Environmental Landscape 6.2.3. Social Landscape 6.2.4. Technology Landscape 6.2.5. Legal Landscape 6.3. Major Deals And Strategic Alliances Analysis 6.3.1. Joint Ventures 6.3.2. Mergers and Acquisitions 6.3.3. Licensing and Partnership 6.3.4. Technology Collaborations 6.3.5. Strategic Divestments 6.4. Market Entry Strategies 6.5. Case Studies
7. Multiplex Assay Market, By Product and Service Historical Analysis and Forecast 2022-2028 (USD Million) 7.1. Consumables 7.2. Instruments 7.3. Software and Services
8. Multiplex Assay Market, By Type Historical Analysis and Forecast 2022-2028 (USD Million) 8.1. Protein Multiplex Assays 8.1.1. Planar Protein Assays 8.1.2. Bead-Based Protein Assays 8.1.3. Other Protein Assays 8.2. Nucleic Acid Multiplex Assays 8.2.1. Planar Nucleic Acid Assays 8.2.2. Bead-Based Nucleic Acid Assays 8.2.3. Other Nucleic Acid Assays 8.3. Cell-Based Multiplex Assays
9. Multiplex Assay Market, By Technology Historical Analysis and Forecast 2022-2028 (USD Million) 9.1. Flow Cytometry 9.2. Fluorescence Detection 9.3. Luminescence 9.4. Multiplex Real-Time PCR 9.5. Other Technologies
10. Multiplex Assay Market, By Applications Historical Analysis and Forecast 2022-2028 (USD Million) 10.1. Research & Development 10.1.1. Drug Discovery & Development 10.1.2. Biomarker Discovery & Validation 10.2. Clinical Diagnostics 10.2.1. Infectious Diseases 10.2.2. Cancer 10.2.3. Cardiovascular Diseases 10.2.4. Autoimmune Diseases 10.2.5. Nervous System Disorders 10.2.6. Metabolism & Endocrinology Disorders 10.2.7. Other Diseases
11. Multiplex Assay Market, By End User Historical Analysis and Forecast 2022-2028 (USD Million) 11.1. Pharmaceutical & Biotechnology Companies 11.2. Hospitals & Research Institutes 11.3. Reference Laboratories 11.4. Other End Users
12. North America Multiplex Assay Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 12.1. Introduction 12.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 12.2.1. U.S.A 12.2.2. Canada 12.2.3. Mexico 12.3. Market Size (USD Million) Forecast for North America 2022-2028
13. Latin America Multiplex Assay Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 13.1. Introduction 13.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 13.2.1. Brazil 13.2.2. Venezuela 13.2.3. Argentina 13.2.4. Rest of Latin America 13.3. Market Size (USD Million) Forecast for Latin America 2022-2028
14. Europe Multiplex Assay Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 14.1. Introduction 14.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 14.2.1. Germany 14.2.2. U.K 14.2.3. France 14.2.4. Italy 14.2.5. Spain 14.2.6. Russia 14.2.7. Poland 14.2.8. Rest of Europe 14.3. Market Size (USD Million) Forecast for Europe 2022-2028
15. Asia Pacific Multiplex Assay Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 15.1. Introduction 15.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 15.2.1. Japan 15.2.2. China 15.2.3. India 15.2.4. Australia and New Zealand 15.2.5. ASEAN 15.2.6. Rest of Asia Pacific 15.3. Market Size (USD Million) Forecast for Asia Pacific 2022-2028
16. Middle East and Africa Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 16.1. Introduction 16.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 16.2.1. GCC 16.2.2. Israel 16.2.3. South Africa 16.2.4. Rest of MEA 16.3. Market Size (USD Million) Forecast for MEA 2022-2028
17. Market Share Analysis and Competitive Landscape 17.1. Global Landscape - Key Players, Revenue and Presence 17.2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3) 17.3. Global Emerging Companies 17.4. North America - Market Share Analysis and Key Regional Players 17.5. Europe - Market Share Analysis and Key Regional Players 17.6. Asia Pacific - Market Share Analysis and Key Regional Players 17.7. Global Key Player - Growth Matrix
18. Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts) 18.1. Abbott Laboratories 18.1.1. Company Overview 18.1.2. Product Portfolio 18.1.3. SWOT Analysis 18.1.4. Financial Overview 18.1.5. Strategic Overview 18.2. Hoffmann-La Roche 18.2.1. Company Overview 18.2.2. Product Portfolio 18.2.3. SWOT Analysis 18.2.4. Financial Overview 18.2.5. Strategic Overview 18.3. Siemens Healthineers 18.3.1. Company Overview 18.3.2. Product Portfolio 18.3.3. SWOT Analysis 18.3.4. Financial Overview 18.3.5. Strategic Overview 18.4. Thermo Fisher Scientific 18.4.1. Company Overview 18.4.2. Product Portfolio 18.4.3. SWOT Analysis 18.4.4. Financial Overview 18.4.5. Strategic Overview 18.5. Danaher Corporation 18.5.1. Company Overview 18.5.2. Product Portfolio 18.5.3. SWOT Analysis 18.5.4. Financial Overview 18.5.5. Strategic Overview 18.6. Bio-Rad Laboratories 18.6.1. Company Overview 18.6.2. Product Portfolio 18.6.3. SWOT Analysis 18.6.4. Financial Overview 18.6.5. Strategic Overview 18.7. Biomérieux 18.7.1. Company Overview 18.7.2. Product Portfolio 18.7.3. SWOT Analysis 18.7.4. Financial Overview 18.7.5. Strategic Overview 18.8. Bühlmann Laboratories 18.8.1. Company Overview 18.8.2. Product Portfolio 18.8.3. SWOT Analysis 18.8.4. Financial Overview 18.8.5. Strategic Overview 18.9. Sekisui Medical 18.9.1. Company Overview 18.9.2. Product Portfolio 18.9.3. SWOT Analysis 18.9.4. Financial Overview 18.9.5. Strategic Overview 18.10.Randox Laboratories 18.10.1. Company Overview 18.10.2. Product Portfolio 18.10.3. SWOT Analysis 18.10.4. Financial Overview 18.10.5. Strategic Overview 19. Pre and Post COVID-19 Impact 19.1. Positive influence on the healthcare industry 19.2. The financial disruption of the manufacturing sector 19.3. Impact of COVID-19 on emerging companies 19.4. Significant mandates in the healthcare regulations initiated by administrations 19.5. The overall economic slowdown of the developing and developed nations
20. FutureWise SME Key Takeaway Points for Client
UK : +44 141 628 9353 US : +1 347 709 4931
OR
Excel Dataset
Infographics
PDF Report
Market Overview
PowerPoint Presentation
Consumer Perception and Procurement
Competitive Analysis
What’s Next
Market Data Forecast
Risks and Opportunity Assessment
Market Trends and Dynamics